Lyophilization: A Primer - Optimized freeze-drying cycles can offer scientific and business advantages. - BioPharm International

ADVERTISEMENT

Lyophilization: A Primer
Optimized freeze-drying cycles can offer scientific and business advantages.


BioPharm International
Volume 26, Issue 3, pp. 46-51


Katriona Scoffin
Freeze drying, or lyophilization, is a stabilization method that is widely used in the pharmaceutical industry for drugs, vaccines, antibodies, and other biological material. Because the product is dried without excessive heating, proteins and other products that would be thermally denatured can be successfully preserved without loss of activity.

Freeze-dried products have a very high surface area, which enables them to be reconstituted quickly. This quick reconstitution is particularly important in the case of emergency vaccines and antibodies, which need to be administered as soon as possible.

Every formulation has different freeze-drying characteristics and, therefore, different processing requirements. To ensure cycles are both robust and efficient, they should be tailor-made for each formulation. Failure to do so can lead to inconsistent dryness across samples, reduced stability during storage, and reduced activity on rehydration.

There are three main business advantages of optimizing a product's lyophilization cycle:
  • Financial gain: optimal lyophilization cycles use only the energy and time required, shortening process time and increasing product throughput.
  • Product excellence: a well-dried product exhibits a long shelf life and maximum activity on rehydration.
  • Quality and regulatory assurance: consistency throughout batches is assured and regulatory submissions are completed with the inclusion of lyophilization cycle data.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Merck KGaA Announces Acquisition of Sigma-Aldrich for $17 Billion
September 22, 2014
Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Author Guidelines
Source: BioPharm International,
Click here